The association of CCND1 and HER-2/neu gene locations within the respective chromosome territories, together with gene amplification and over-expression of these two molecular targets, is shown in Tables 3  and 4 for esophageal carcinoma and gastric adenocarcinoma, respectively. This evidence concerns the gene CCND1 and gastric adenocarcinoma.